ADVANCING THE COMMERCIALIZATION OF DIGITAL MEDICINES
Join EVERSANA at a number of virtual events as we work to advance the commercialization of digital medicines.
“While advancements in digital medicine take us into a new frontier, these devices can and should be available through existing prescription, distribution and reimbursement infrastructures. The commercial model for digital medicine will be efficient, effective and valuable to payers, providers and most importantly, for the patients and caregivers who need them.” Jim Lang, CEO, EVERSANA
For more information on the work we do for Digital Therapeutics or to schedule an appointment with one of our Subject Matter Experts, please contact Jon Kizner by completing our contact us form.
EVERSANA – Knowledge Partner
DTx East: September 16-18
DTx London: October 20-22
Join the EVERSANA team at the DTX East and where our experts will be discussing commercializing digital medicines, especially in this new world:
- Session Title: Specialty Pharmacy? Why Do I Need One For My Prescription DTx?
- Ed Cox, EVP, Strategic Alliances & Global Head of Digital Medicine
- Tom Doyle, Sr. VP, Global Accounts, Strategic
- Brian Davis, VP, Strategy & Innovation
As a Knowledge Partner, EVERSANA brings a number of solutions to alleviate the barriers facing the adoption of digital therapeutics – from reimbursement strategies, distribution, dispensing, patient engagement and adherence programs.
To schedule a meeting with our Digital Medicine experts, contact us here.